| Firm | Analyst |
|---|---|
| Bloom Burton Securities Inc | David Martin |
| Canaccord Genuity* | Suspended |
| Echelon | Stefan Quenneville |
| Raymond James | Rahul Sarugaser |
| Research Capital | Andre Uddin |
| Roth Capital Partners* | Suspended |
| Stifel GMP | Justin Keywood, CFA |
*Coverage is temporarily suspended due to analyst vacancy.
Medexus Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Medexus Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Medexus Pharmaceuticals, Inc. or its management. Medexus Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.